The Oncosearch | Oncotarget

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs Research Paper

Joshua E. E. Allen, Bikramajit Singh Saroya, Miriam Kunkel, David . T. Dicker, Avisnata Das, Kristi L. Peters, Jamal Joudeh, Junjia Zhu, Wafik S. El-Deiry

Published Oct 17, 2013 · Vol. 5, No. 7 · pp. 1753-1760

The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth Research Paper

Elena Kurenova, Jianqun Liao, Di-Hua He, Darrell Hunt, Michael Yemma, Wiam Bshara, Mukund Seshadri, William G Cance

Published Sep 30, 2013 · Vol. 4, No. 10 · pp. 1632-1646

Keywords: FAK Scaffold Inhibitor, pancreatic cancer, FAK-VEGFR-3 interaction, protein-protein interaction

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma Research Paper

Andrea Treszl, Zita Steiber, Andrew V Schally, Norman L Block, Balazs Dezso, Gabor Olah, Bernadett Rozsa, Klara Fodor, Armin Buglyo, Janos Gardi, Andras Berta, Gabor Halmos

Published Sep 10, 2013 · Vol. 4, No. 10 · pp. 1721-1728

Keywords: uveal melanoma, luteinizing hormone-releasing hormone (LHRH) receptor

Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? Editorial

Gerald Willimsky, Ulrike Protzer, Percy Knolle, Mathias Heikenwalder

Published Jul 15, 2013 · Vol. 4, No. 8 · pp. 1117-1118

P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy Research Paper

Rabih Said, David S. Hong, Carla L. Warneke, J. Jack Lee, Jennifer J. Wheler, Filip Janku, Aung Naing, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Apostolia M. Tsimberidou, Razelle Kurzrock

Published May 1, 2013 · Vol. 4, No. 5 · pp. 705-714

Keywords: P53 mutations, PTEN loss, bevacizumab, Li-Fraumeni syndrome

Tumorigenic potential of circulating prostate tumor cells Research Paper

Filipe LF. Carvalho, Brian W. Simons, Emmanuel S. Antonarakis, Zeshaan Rasheed, Nora Douglas, Daniela Villegas, William Matsui, David M. Berman

Published Mar 5, 2013 · Vol. 4, No. 3 · pp. 413-421

Keywords: Circulating tumor cells, EpCAM, prostate cancer, prostate-specific antigen, TRAMP mouse

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes Research Paper

Filip Janku, Jennifer J. Wheler, Aung Naing, Vanda M. T. Stepanek, Gerald S. Falchook, Siqing Fu, Ignacio Garrido-Laguna, Apostolia M. Tsimberidou, Sarina A. Piha-Paul, Stacy L. Moulder, J. Jack Lee, Rajyalakshmi Luthra, David S. Hong, Razelle Kurzrock

Published Nov 30, 2012 · Vol. 3, No. 12 · pp. 1566-1575

Keywords: PIK3CA mutation, phenotypic taxonomy, clinical outcome

FAK is a critical regulator of neuroblastoma liver metastasis Research Paper

Sora Lee, Jingbo Qiao, Pritha Paul, Kathleen L. Oâ€™Connor, Mark Evers, Dai H. Chung

Published Nov 16, 2012 · Vol. 3, No. 12 · pp. 1576-1587

Keywords: GRP-R, FAK, malignant transformation, metastasis, neuroblastoma

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects Research Paper

Quteba Ebrahem, Reda Z Mahfouz, Kwok Peng Ng, Yogen Saunthararajah

Published Sep 27, 2012 · Vol. 3, No. 10 · pp. 1137-1145

Keywords: cytidine analogues, decitabine, cytidine deaminase, chemotherapy resistance, sanctuary

Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation Research Paper

Mathias Dahlmann, Ulrike Sack, Pia Herrmann, Margit Lemm, Iduna Fichtner, Peter M. Schlag, Ulrike Stein

Published Aug 7, 2012 · Vol. 3, No. 8 · pp. 783-797

Keywords: colorectal, cancer, metastasis, S100A4, RNAi

Targeting Cancer Gene Therapy with Magnetic Nanoparticles Review

Charles Li, Linda Li, Andrew C. Keate

Published May 2, 2012 · Vol. 3, No. 4 · pp. 365-370

Keywords: Magnetic targeting, Magnetical nanoparticles, xenograft tumors models

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon Review

Melchiorre Cervello, James A McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto

Published Mar 31, 2012 · Vol. 3, No. 3 · pp. 236-260

Keywords: HCC, signaling pathways, EGF/EGFR, Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR, Wnt/Î²-catenin

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Research Paper

Yan Hu, Mary L. Spengler, Karen K. Kuropatwinski, Maria Comas, Marilyn Jackson, Mikhail V. Chernov, Anatoly S. Gleiberman, Natalia Fedtsova, Youcef M. Rustum, Andrei V. Gudkov, Marina Antoch

Published Dec 31, 2011 · Vol. 2, No. 12 · pp. 1279-1290

Keywords: L-Methyl-selenocysteine, TIEG1, circadian rhythms, cyclophosphamide, anticancer treatment, liver, transcription

Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis Research Paper

Patricia Alexandra Madureira, Richard Hill, Victoria Ann Miller, Carman Giacomantonio, Patrick WK Lee, David Morton Waisman

Published Dec 20, 2011 · Vol. 2, No. 12 · pp. 1075-1093

Keywords: ANXA2, reactive oxygen species (ROS), redox regulation, oxidative stress, tumorigenesis

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis Research Paper

Published May 22, 2011 · Vol. 2, No. 5 · pp. 393-400

Keywords: pyruvate kinase, proteomics, cancer metabolism, alternative splicing, Warburg effect.

Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma? Research Perspective

Mihael Vucur, Christoph Roderburg, Kira Bettermann, Frank Tacke, Mathias Heikenwalder, Christian Trautwein, Tom Luedde

Published Sep 13, 2010 · Vol. 1, No. 5 · pp. 373-378

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs Research Paper

The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth Research Paper

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma Research Paper

Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? Editorial

P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy Research Paper

Tumorigenic potential of circulating prostate tumor cells Research Paper

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes Research Paper

FAK is a critical regulator of neuroblastoma liver metastasis Research Paper

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects Research Paper

Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation Research Paper

Targeting Cancer Gene Therapy with Magnetic Nanoparticles Review

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon Review

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Research Paper

Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis Research Paper

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis Research Paper

Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma? Research Perspective

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs Research Paper

The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth Research Paper

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma Research Paper

Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? Editorial

P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy Research Paper

Tumorigenic potential of circulating prostate tumor cells Research Paper

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes Research Paper

FAK is a critical regulator of neuroblastoma liver metastasis Research Paper

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects Research Paper

Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation Research Paper

Targeting Cancer Gene Therapy with Magnetic Nanoparticles Review

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon Review

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Research Paper

Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis Research Paper

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis Research Paper

Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma? Research Perspective